The rise of Sildenafil initially sparked a surge for the drug industry, but recent developments present a uncertain scenario for shareholders. Lower-cost alternatives are reducing earnings, and ongoing legal battles https://sashamlhi790314.blogoxo.com/41565581/sildenafil-and-big-pharma-a-precarious-investment